Evaluation of in vitro and in vivo Efficacy of a Novel Amphotericin B-Loaded Nanostructured Lipid Carrier in the Treatment of Leishmania braziliensis Infection

BACKGROUND: Leishmaniasis is a neglected disease, and the current therapeutic arsenal for its treatment is seriously limited by high cost and toxicity. Nanostructured lipid carriers (NLCs) represent a promising approach due to high drug loading capacity, controlled drug release profiles and superior...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Nanomedicine
Autores principales: Rebouças-Silva, Jéssica, Tadini, Maraine Catarina, Devequi-Nunes, Danielle, Mansur, Ana Luíza, S Silveira-Mattos, Paulo, I de Oliveira, Camila, R Formiga, Fábio, Berretta, Andresa A, Marquele-Oliveira, Franciane, Borges, Valéria M
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7652360/
https://ncbi.nlm.nih.gov/pubmed/33177824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S262642
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares